Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
about
Prediction of Lymph Node Metastases in Gastric Cancer by Serum APE1 ExpressionGlycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerSerum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancerLung cancer screening with CTHelminths and the microbiota: parts of the hygiene hypothesis.Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Occupational toxicology of asbestos-related malignancies.ISPIDER Central: an integrated database web-server for proteomicsMagnetic nanoparticle-enhanced SPR on gold nanoslits for ultra-sensitive, label-free detection of nucleic acid biomarkers.Carotenoid Biosynthesis in Calothrix sp. 336/3: Composition of Carotenoids on Full Medium, During Diazotrophic Growth and After Long-Term H2 Photoproduction.Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer.Plasma marker proteins associated with the progression of lung cancer in obese mice fed a high-fat diet.Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer.[Preliminary results of metabolite in serum and urine of lung cancer patients detected by metabolomics].
P2860
Q33820896-0274002F-724A-4CB0-AE83-399D6AC392CEQ33888457-CE59BA21-5723-4865-8367-551BB35FF9C9Q33893239-7272F2B9-9869-4230-8664-E1580B19CB8EQ34148738-E3C92485-DFC1-41C9-8AD3-B8F5B3D36AD3Q34532251-EC010D62-2502-45FD-9F14-20381FA993C2Q34614608-03039A4C-EE5E-42EE-B3E4-A77C3713FF94Q35018681-1B506AC0-0892-4D0E-B6B1-F972C156FBC9Q35597586-0332959C-1E7A-4867-A4C9-8E40B43973E6Q36745834-4A7DE4EA-2854-44E8-B4C5-AC681578E1DCQ37484011-DFCBF324-C2C3-43BD-B770-378A3D486ED1Q37789759-4CFAD726-72C3-4E05-9C72-944DE7A092B4Q38390705-3AA9598A-1252-4869-908A-99EA17443739Q39178339-719258DD-8C82-43CE-9943-164759930FF3Q51202861-8975329F-BDC2-480C-8A4C-5CD4B242ED2CQ51688314-A0371160-A05F-4569-8902-F22DFA231A0DQ53369907-A794D82C-440E-4D52-9B35-D25FE3F3C968Q54378597-3C0FAC85-1070-4C08-B6D2-E1846F99D50EQ55437268-090E7A41-EEF7-4318-86DC-D02DFF910C46
P2860
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@ast
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@en
type
label
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@ast
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@en
prefLabel
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@ast
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@en
P2860
P356
P1476
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
@en
P2093
Patrick C Ma
P2860
P304
P356
10.1002/MAS.20125
P577
2007-05-01T00:00:00Z